Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dendritech
Midland, Michigan, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Dendritech is the only large-scale manufacturer dedicated to poly(amidoamine) (PAMAM) dendrimers, supporting commercial platforms in clinical diagnostics and pharmaceutical development. Their materials have been incorporated in commercial diagnostic assays and have supported clinical evaluation of experimental drugs for neurological diseases[1][4].
- Therapeutic areas
- CardiovascularImmunologyInfectious DiseasesNeurologyOtherOncology
- Modalities
- Poly(amidoamine) dendrimerDendrimerPolymer-drug conjugate therapy
- Industry
- Chemicals & Materials
02
Partnerships
Half a dozen leading companies in diagnostic assays (unnamed)[1]
Beyond the preview
Go deeper on Dendritech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dendritech.